Concepedia

Impurity Profiling Method Development

Impurity Profiling Method Development is a methodological contribution in analytical chemistry that involves the systematic design and optimization of analytical procedures specifically intended to identify, characterize, and quantify impurities in pharmaceutical substances or products, distinguishing it from other method development processes by its exclusive focus on impurity detection, structural elucidation, and stability-indicating capability.

120

Publications

3.8K

Citations

505

Authors

157

Institutions

Publications per year

2017–2026

19

Parents

Publications

120

The importance of impurity analysis in pharmaceutical products: an integrated approach

Nafisur Rahman, Syed Najmul Hejaz Azmi, Hui‐Fen Wu · Accreditation and Quality Assurance · 2006 · 182 citations

, , +16

Essential peak area normalisation for quantitative impurity content determination by capillary electrophoresis

Kevin D. Altria · Chromatographia · 1993 · 142 citations

, , +16

The importance and the challenges of impurity profiling in modern pharmaceutical analysis

Sándor Gǒrög · TrAC Trends in Analytical Chemistry · 2006 · 127 citations

, , +14

‘Quality by Design’ approach for the analysis of impurities in pharmaceutical drug products and drug substances

Amandine Dispas, H. Avohou, Pierre Lebrun et al. · TrAC Trends in Analytical Chemistry · 2017 · 118 citations

, , +17

Review on Pharmaceutical Impurities, Stability Studies and Degradation Products: An Analytical Approach

ZeidA. Alothman, Nafisur Rahman, Masoom Raza Siddiqui · Reviews in Advanced Sciences and Engineering · 2013 · 110 citations

, , +17

1–5 of 120

Authors

505

  1. SG
    Sándor Gǒrög

    Gedeon Richter (Hungary), Hungary

    11 publications · 574 citations

    11

    h-index

  2. MG
    M. Gazdag

    Gedeon Richter (Hungary), Hungary

    5 publications · 130 citations

    5

    h-index

  3. JB
    J. BRLIK

    Gedeon Richter (Hungary), Hungary

    4 publications · 145 citations

    4

    h-index

  4. GB
    Gábor Balogh

    Institute of Biochemistry, Hungary

    4 publications · 148 citations

    4

    h-index

  5. YV
    Yvan Vander Heyden

    Vrije Universiteit Brussel, Belgium

    4 publications · 142 citations

    4

    h-index

1–5 of 505

Institutions

157

  1. Gedeon Richter (Hungary)

    Budapest, Hungary

    13 h-index

    59 publications

    2.2K citations

  2. Eli Lilly (United States)

    Indianapolis, United States

    5 h-index

    15 publications

    445 citations

  3. Vrije Universiteit Brussel

    Brussels, Belgium

    4 h-index

    13 publications

    606 citations

  4. Dr. Reddy's Laboratories (India)

    Hyderabad, India

    4 h-index

    24 publications

    570 citations

  5. Jawaharlal Nehru Technological University, Hyderabad

    Hyderabad, India

    4 h-index

    5 publications

    117 citations

  6. Pfizer (United States)

    New York, United States

    3 h-index

    20 publications

    916 citations

  7. AstraZeneca (Sweden)

    Södertälje, Sweden

    3 h-index

    7 publications

    282 citations

  8. Cairo University

    Giza, Egypt

    3 h-index

    10 publications

    225 citations

1–8 of 157

Venues

  1. Journal of Pharmaceutical and Biomedical Analysis

    44 publications · 1.1K citations

    23

    h-index

  2. Journal of Chromatography A

    8 publications · 256 citations

    8

    h-index

  3. Analytica Chimica Acta

    5 publications · 104 citations

    5

    h-index

  4. Chromatographia

    4 publications · 206 citations

    4

    h-index

  5. TrAC Trends in Analytical Chemistry

    4 publications · 411 citations

    4

    h-index

1–5